Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsBioAegis Therapeutics announced that the first patient has been enrolled in the company’s Phase III study of rhu-pGSN for the treatment of ARDs.
[BioAegis Therapeutics]
Home Newsletters BioAegis Therapeutics Enrolls First Patient in Phase II Clinical Trial of Gelsolin,...
